Q60.1
Renal agenesis, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Bilateral renal agenesis is a rare congenital condition characterized by the absence of both kidneys at birth. This serious anomaly occurs during fetal development, leading to significant health implications for the newborn. Since the kidneys are vital for filtering waste from the blood and maintaining fluid and electrolyte balance, their absence results in critical life-threatening issues shortly after birth if not managed appropriately. The condition is classified under ICD-10 as Q60.1 and typically requires prompt medical intervention and coordinated care among specialists.
Causes & Symptoms
Clinical Causes: Genetic mutations or chromosomal abnormalities may contribute to the development of bilateral renal agenesis. Disruptions during the embryonic development of the urinary system, specifically the ureteric bud and metanephric mesenchyme, can lead to this condition. Environmental factors such as maternal exposure to certain drugs, toxins, or infections during pregnancy have been linked in some cases. In many instances, the exact cause remains unknown, indicating a complex interplay of genetic and environmental factors.
Key Symptoms: Absence of kidneys detected in prenatal ultrasound examinations. Oligohydramnios: a reduced amount of amniotic fluid during pregnancy, leading to a distinct 'stuck-on' appearance of the fetus. Signs of respiratory distress or other complications soon after birth due to associated anomalies. Potential presence of other congenital anomalies, particularly of the cardiovascular, skeletal, or nervous systems.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of bilateral renal agenesis is primarily made through prenatal imaging techniques, such as ultrasound, which can reveal the absence of fetal kidneys and decreased amniotic fluid. MRI may be used for further evaluation when ultrasound findings are inconclusive. Postnatally, physical examinations and imaging studies like renal ultrasound or MRI confirm the absence of kidneys. Additionally, the presence of oligohydramnios during pregnancy and the detection of other anomalies can support the diagnosis.
Treatment Protocols: Bilateral renal agenesis is a life-threatening condition because the kidneys are essential for survival. As such, immediate postnatal management focuses on supportive care. This may include intensive respiratory support, fluid management, and treatment of associated complications. In some cases, infants may be considered for renal replacement therapy, such as dialysis, or be evaluated for kidney transplantation, although these options are limited and depend on individual health factors. Prenatal interventions are generally not effective for this condition. The prognosis remains poor, emphasizing the importance of early diagnosis and multidisciplinary care planning.
Clinical Advice & FAQs
Billing Guidance
Is Q60.1 a billable ICD-10 code?
Yes, Q60.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q60.1?
Clinical documentation must specify the nature of Renal agenesis, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference